## Abstract Initial evaluation of a new blood pool agent, B‐22956/1, for pulmonary imaging was performed in five domestic pigs with artificial embolism. Pre‐embolism 3D pulmonary perfusion images were first acquired by injecting an extravascular agent, gadoteridol. The pulmonary arteries of the pig
Optimization of a blood pool contrast agent injection protocol for MR angiography
✍ Scribed by Philippe Robert; Xavier Violas; Robin Santus; Denis Le Bihan; Claire Corot
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 256 KB
- Volume
- 21
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Purpose
To design an ideal first‐pass profile for MR angiography (MRA) by optimizing a multiphasic injection protocol based on two experimental animal models.
Materials and Methods
An equivalent contrast‐enhanced (CE) MRA injection protocol was developed with controlled injection modalities (injection rate, volume, and dose) in rabbits and pigs. P792, a blood pool contrast agent, was injected in 17 male New Zealand rabbits and five farm pigs with variable injection schemes (mono‐ and multiphasic). From the gadolinium (Gd) blood concentration data, a simulation of an MR acquisition was performed to evaluate the impact of such an injection protocol on MR arterial signal and to select the best injection protocol.
Results
An empirical relationship between the arterial peak concentration and the injection parameters was found in the rabbits and pigs, allowing precise prediction of the first‐pass profile. Of the four injection scheme strategies tested (standard bolus and bi‐, tri‐, and multiphasic injection protocols), the multiphasic “ramp” injection protocol provided the most optimal contrast agent pharmacokinetics with a durable plateau of concentration.
Conclusion
Ramp injection protocol provides an optimized first‐pass profile for CE‐MRA. J. Magn. Reson. Imaging 2005;21:611–619. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## Purpose: To optimize the contrast agent dose and delivery rate used in a novel whole‐body magnetic resonance angiography (MRA) protocol using a 3.0T MR scanner. ## Materials and Methods: Six groups of 20 consenting volunteers underwent whole‐body MRA, with each group receiving a d